LYFE Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 18

Professionals
  • Investments
  • 103

  • Portfolio
  • 67

  • Exits
  • 19

Exits

LYFE Capital General Information

Description

Founded in 2015, LYFE Capital is a venture capital firm based in Shanghai, China. The firm prefers to make investment in the biotechnology, pharmaceutical, medical devices, and healthcare sectors. The firm has additional offices in Hong Kong and Menlo Park.

Contact Information

Year Founded
2015
Investor Status
Actively Seeking New Investments
Trade Association
Hong Kong Venture Capital Association (HKVC)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Park Place, 1601 West Nanjing Road
  • Suite 3204-3205
  • Shanghai, 200040
  • China
+86 021 0000 0000

LYFE Capital Investments (103)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
iECURE 30-Nov-2022 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 00000 0000
000000000 00000000 21-Sep-2022 00000 00000 000.00 Biotechnology Generating Revenue
000000000 31-Aug-2022 00000 00000 000.00 Biotechnology Generating Revenue
00000000 0000000 25-Jul-2022 00000 00000 000.00 Biotechnology Generating Revenue 000000 000
00000000000 02-Jun-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
00000 000000000000 09-May-2022 00000 00000 00000 Drug Discovery Pre-Clinical Trials
0000000 0000000 09-May-2022 00000 00000 000.00 Medical Supplies Generating Revenue
000000 29-Apr-2022 00000 00000 Surgical Devices Generating Revenue
Starna Therapeutics 19-Apr-2022 Early Stage VC 000.00 Drug Discovery Startup
Levostar Life Sciences 11-Apr-2022 Seed Round Biotechnology Startup 00000 00
You’re viewing 10 of 103 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LYFE Capital Exits (19)

Company Name Exit Date Exit Type Exit Size
Canopus Medical 30-Nov-2022 IPO 00000
0&0 0000000000000 02-Aug-2022 000 00000
000000000 20-Apr-2022 000 00 00000000
000000 30-Mar-2022 000 000.00
000000000 000000 10-Dec-2021 000 000.00
00000 15-Nov-2021 000 00000
00000000000 30-Jul-2021 000 00000
00000 23-Jul-2021 000 00000
Tempest Therapeutics 28-Jun-2021 Reverse Merger
Angelalign 09-Jun-2021 IPO 00000
You’re viewing 10 of 19 exits. Get the full list »

LYFE Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore LYFE Capital‘s full profile, request access.

Request a free trial

LYFE Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

LYFE Capital Team (23)

Name Title Deals Funds Boards Office
Roy Xu Chief Financial Officer Shanghai, China
Anthony Walsh Ph.D Managing Director Shanghai, China
Tian Jing Managing Director Menlo Park, CA
William Chen Managing Director 0 Shanghai, China
Yanfei Feng Managing Director Shanghai, China
You’re viewing 5 of 23 team members. Get the full list »

LYFE Capital Co-Investors (221)

Name With Exits Lead Partner Series Industry
Jifeng Ventures 8 0 0 Series chart Industry bar
Sequoia Capital China 0 0 0 Series chart Industry bar
Hillhouse Capital Group 0 0 Series chart Industry bar
Legend Capital 0 0 Series chart Industry bar
Lilly Asia Ventures 0 0 0 Series chart Industry bar
You’re viewing 5 of 221 co-investors. Get the full list »